Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Magnetic Stimulation (rTMS) for the Treatment of Focal Refractory Epilepsy: Neuropsychological and Electrophysiological Evaluation.

NCT06681480 is registered in ClinicalTrials.gov with Comenius University as lead sponsor.

NCT NCT06681480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Magnetic Stimulation (rTMS) for the Treatment of Focal Refractory Epilepsy: Neuropsychological and Electrophysiological Evaluation.
Lead sponsor
Comenius University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2022
Completion date
April 30, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focal epilepsy, transcranial magnetis stimulation